Pharmaceutical
raw materials |
CAS No |
pecification |
| ALIBENDOL |
26750-81-2 |
98.5% min |
| GENTISIC
ACID |
490-79-9 |
99% min |
PRANLUKAST
HEMIHYDRATE  |
113712-98-4 |
98% min |
| REBAMIPIDE |
111911-87-6 |
99% min |
| SODIUM
GENTISATE |
4955-90-2 |
99% min |
| Thalidomide |
50-35-1 |
98% min |
| Voglibose |
83480-29-9 |
98% min |
| 3-Chloro-1,2-propanediol |
96-24-2 |
99.5%(GC) min |
| 3-Amino-1,2-propanediol |
616-30-8 |
≥99.7%(GC) min |
| 3-Methylamino-1,2-propanediol |
40137-22-2 |
≥99.5%(GC) min |
| 2-Amino-1,3-propanediol |
534-03-2 |
≥98.0%(GC) min |
| 5-Nitroisophthalic acid |
618-88-2 |
99.5%(HPLC) min |
| Dimethyl 5-nitroisophthalate |
13290-96-5 |
99.5%(HPLC) min |
| 5-Aminoisophthalic acid |
99-31-0 |
99.0%(HPLC)min |
| N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide |
76820-34-3 |
99.0%(HPLC) min |
| 3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine |
108157-52-4 |
98.0(HPLC) min |
| (S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine |
147769-93-5 |
98.0(HPLC) min |
| (R)-(-)-Epichlorohydrin |
51594-55-9 |
99.0% (GC) min
99.0% (E.E.) min |
| (S)-(+)-Epichlorohydrin |
67843-74-7 |
99.0% (GC) min
99.0% (E.E.) min |
| (R)-(-)-3-Chloro-1,2-propanediol |
57090-45-6 |
99.0% (GC) min
99.0% (E.E.) min |
| (S)-(+)-3-Chloro-1,2-propanediol |
60827-45-4 |
99.0% (GC) min
99.0% (E.E.) min |
| Diclofenac sodium |
15307-79-6 |
|
| 1-(2,6-Dichlorophenyl)indolin-2-one |
15362-40-0 |
|
| 3-Hydroxyacetophenone |
121-71-1 |
|
| 4-Hydroxyacetophenone |
99-93-4 |
|
| 2,4-dihydroxyacetophenone |
89-84-9 |
|
| 2,6-dihydroxyacetophenone |
699-83-2 |
|
| Triclabendazole |
68786-66-3 |
|
